-
- Ahsan Waquar
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
-
- Javed Shamama
- Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
-
- Bratty Mohammed Al
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
-
- Alhazmi Hassan A.
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, Saudi Arabia. Substance Abuse and Toxicology Research Centre, Jazan University, Jazan, Saudi Arabia.
-
- Najmi Asim
- Department of Pharmaceutical Chemistry, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
この論文をさがす
説明
<p>The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries and territories worldwide. It has been declared as pandemic by World Health Organization (WHO) and the whole world is suffering from corona virus disease 2019 (COVID-19). Currently, no treatment for SARS-CoV-2 are approved because of lack of evidence, but a number of clinical trials are in process and we are expecting fruitful results very soon. This review focuses on various approaches of treatment and few of the most recent clinical trials carried out in this field.</p>
収録刊行物
-
- Drug Discoveries & Therapeutics
-
Drug Discoveries & Therapeutics 14 (2), 67-72, 2020-04-30
特定非営利活動法人 バイオ＆ソーシャル・サイエンス推進国際研究交流会